Tin tức & Cập nhật

Initiating dual antiplatelet therapy (DAPT) within 24 h of onset of a minor ischaemic stroke or transient ischaemic attack (TIA) yields the greatest clinical benefit, with the therapeutic effect declining progressively beyond this period, as shown in a study.

In the treatment of acute ischaemic stroke in patients with recent direct oral anticoagulant (DOAC) use, intravenous thrombolysis appears to be safe and is associated with improvements in functional outcomes, according to a study.

Influenza immunization at midlife neither increases nor reduces the risk of Parkinson’s disease (PD), as shown in a study.

Among commonly used antiseizure medications (ASMs), topiramate appears to result in weight loss at 6 and 12 months under either initiation and subsequent adherence or initiation-only effects, reports a study. Other ASMs seem to contribute to greater weight change.

New drug applications approved by US FDA as of 16-31 December 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The significantly poorer health-related quality of life (HRQoL) in patients with chronic vertigo and dizziness compared with those without, following a stroke, necessitates systematic poststroke screening, comprehensive multidisciplinary assessment and individualized rehabilitation, according to a stroke cohort study.

Treatment with lubiprostone is associated with an increased risk of headache in adults and children, according to a recent meta-analysis.